Zdrowie i gospodarka · 22/04/2016

FDA Extends Public Hearing on Human Cells, Tissues, and Cellular and Tissue-Based Products Guidance Documents

The Food and Drug Administration (FDA) is rescheduling a public hearing to gather input on four draft guidance documents related to the regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps). The hearing, previously postponed from April 13, 2016, will now take place over two days, allowing stakeholders more time to provide comments.